Form SC 13D/A DEPOMED INC Filed by: Starboard Value LP
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/12/2026
- S&P 500 ends higher as strong inflation data cements rate-hike bets
- Oracle raises full year profit guidance, stock rises after hours
- Oil falls but head for 8% weekly gain on tight supply; US diesel hits record
- 'No panic anywhere' may be the problem, BofA strategists warn
- Buy Shopify stock at this ’AI-enabled entry point,’ analyst says
- After-Hours Movers: ORCL, CRWV, ADBE, ACVA, CPRT, ZUMZ, PMTS, RH
- After-Hours Movers: COO, AEO, NAVN, AVAV, TORO
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
Depomed (DEPO) Will Not Pursue Proposed Reincorporation
April 14, 2016 4:58 PM EDTDepomed, Inc. (NASDAQ: DEPO) ("Depomed" or the "Company") today announced that it will not pursue the proposed reincorporation of the Company from California to Delaware that was proposed in its preliminary proxy statement for its upcoming Annual Meeting of Shareholders (the "Annual Meeting").... More
Janney Notes Strong Nucynta Rx Trends for March; Affirms DepoMed (DEPO) at 'Buy'
April 13, 2016 7:57 AM EDTJanney affirms DepoMed (Nasdaq: DEPO) at Buy with a fair value estimate of $28 following a check on recent prescription trends
Analyst Ken Trbovich noted that Nucynta ER prescription growth was 23 percent for March, which came in ahead of the firm's expectations. The analyst... More
